Review of currently available GP IIb/IIIa inhibitors and their role in peripheral vascular interventions

Keyphrases

• Thromboembolism 100%
• Peripheral Vascular Intervention 100%
• Antiplatelet Therapy 33%
• Paucity 33%
• Mechanism of Action 33%
• Peripheral Vascular Disease 33%
• Platelets 33%
• Thrombosis 33%
• Anticoagulants 33%
• Thrombus Formation 33%
• Platelet Aggregation 33%
• Stent 33%
• Cost-effectiveness 33%
• Abciximab 33%
• Pharmacology 33%
• Interventional Radiologist 33%
• Peripheral Arterial 33%
• Endovascular Intervention 33%
• Distal Perfusion 33%
• Antiplatelet Agents 33%
• Arterial Circulation 33%
• Glycoprotein IIb-IIIa 33%
• Unique Mechanism 33%
• Tirofiban 33%
• Eptifibatide 33%
• Arterial Intervention 33%
• Indications for Use 33%

Medicine and Dentistry

• Thromboembolism 100%
• Antiplatelet 33%
• Peripheral Vascular Disease 33%
• Platelet 33%
• Thrombosis 33%
• Blood Clotting 33%
• Antiplatelet Drug 33%
• Thrombocyte Aggregation 33%
• Hope 33%
• Cost-Effectiveness Analysis 33%
• Translating (Language) 33%
• Abciximab 33%
• Anticoagulant 33%
• Interventional Radiologist 33%
• Arterial Circulation 33%
• Fibrinogen Receptor 33%
• Eptifibatide 33%
• Tirofiban 33%